title: Current issues and future perspectives of gastric cancer screening.
abstract: Gastric cancer remains the second leading cause of cancer death worldwide. About half of the incidence of gastric cancer is observed in East Asian countries, which show a higher mortality than other countries. The effectiveness of 3 new gastric cancer screening techniques, namely, upper gastrointestinal endoscopy, serological testing, and "screen and treat" method were extensively reviewed. Moreover, the phases of development for cancer screening were analyzed on the basis of the biomarker development road map. Several observational studies have reported the effectiveness of endoscopic screening in reducing mortality from gastric cancer. On the other hand, serologic testing has mainly been used for targeting the high-risk group for gastric cancer. To date, the effectiveness of new techniques for gastric cancer screening has remained limited. However, endoscopic screening is presently in the last trial phase of development before their introduction to population-based screening. To effectively introduce new techniques for gastric cancer screening in a community, incidence and mortality reduction from gastric cancer must be initially and thoroughly evaluated by conducting reliable studies. In addition to effectiveness evaluation, the balance of benefits and harms must be carefully assessed before introducing these new techniques for population-based screening.
authors.affiliation: Chisato Hamashima, Cancer Screening Assessment and Management Division, Research Center for Cancer Prevention and Screening, National Cancer Center, Tokyo 104-0045, Japan.
authors.forename: Chisato
authors.initials: C
authors.lastname: Hamashima
mesh_terms: D044466:Asian People; D014408:Biomarkers, Tumor / Q000097:blood; D055088:Early Detection of Cancer / Q000379:methods; D005773:Gastroscopy; D006801:Humans; D007564:Japan / Q000453:epidemiology; D011230:Precancerous Conditions / Q000097:blood / Q000175:diagnosis* / Q000208:ethnology / Q000473:pathology / Q000628:therapy; D011237:Predictive Value of Tests; D011379:Prognosis; D018570:Risk Assessment; D012307:Risk Factors; D012698:Serologic Tests; D013274:Stomach Neoplasms / Q000097:blood / Q000175:diagnosis* / Q000208:ethnology / Q000401:mortality / Q000473:pathology / Q000517:prevention & control
chemical_list: D014408:Biomarkers, Tumor
keywords: Gastric cancer screening; Helicobacter pylori antibody; Mortality; Serum pepsinogen test; Upper gastrointestinal X-ray; Upper gastrointestinal endoscopy